CA125 a cause or an effect in heart failure?

被引：4

作者：

Li, Zhuoling ^{[1
]}

Li, Santan ^{[1
]}

机构：

[1] Dongguan Kanghua Hosp, Dept Cardiovasc, Dongguan 523000, Guangdong, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 360卷

关键词：

CA125; Biomarker; Heart failure;

D O I：

10.1016/j.ijcard.2022.05.049

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：77 / 77

页数：1

共 5 条

[1] Screening for Ovarian Cancer [J].

Clarke-Pearson, Daniel L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :170-177

[2] Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure [J].

de la Espriella, Rafael ;

Minana, Gema ;

Santas, Enrique ;

Nunez, Gonzalo ;

Lorenzo, Miguel ;

Nunez, Eduardo ;

Bayes-Genis, Antoni ;

Nunez, Julio .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 :102-105

[3] Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases [J].

Falcao, Felipe ;

de Oliveira, Flavio R. A. ;

da Silva, Maria Cleide F. C. ;

Sobral Filho, Dario C. .

BIOMARKERS IN MEDICINE, 2018, 12 (04) :373-381

[4] CA125 and immunoinflammatory activity in acute heart failure [J].

Minana, Gema ;

Nunez, Julio ;

Sanchis, Juan ;

Bodi, Vicent ;

Nunez, Eduardo ;

Llacer, Angel .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (03) :547-548

[5]

Zeng G., INT J CARDIOL

← 1 →